Contemporary treatment approaches to CMML – Is allogeneic HCT the only cure?
Author:
Funder
Novartis
MSD
Abbvie
Jazz Pharmaceuticals
Neovii
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference65 articles.
1. Turning the tide in myelodysplastic/myeloproliferative neoplasms;Deininger;Nat Rev Cancer,2017
2. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016
3. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12;Srour;Br J Haematol,2016
4. Prognostic score including gene mutations in chronic myelomonocytic leukemia;Itzykson;J Clin Oncol,2013
5. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia;Elena;Blood,2016
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review;Acta Haematologica;2024-06-26
2. Cancer Types;Molecular Targets and Cancer Therapeutics (Part 2);2023-04-19
3. Allogeneic Hematopoietic Stem Cell Transplantation for MDS and CMML: When and How?;Pathogenesis and Treatment of Leukemia;2023
4. Treatment Algorithm of CMML and Other Adult MDS/MPN Subtypes;Pathogenesis and Treatment of Leukemia;2023
5. Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria;Leukemia Research;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3